Decheng Capital Management Iii (Cayman), LLC Portfolio Holdings

Decheng Capital Management Iii (Cayman), LLC

  • $181 Million
  • Q3 2023

Decheng Capital Management Iii (Cayman), LLC has filed its 13F form on November 13, 2023 for Q3 2023 where it was disclosed a total value porftolio of $181 Million distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Zentalis Pharmaceuticals, Inc. with a value of $42.1M, Arcus Biosciences, Inc. with a value of $15.6M, 10x Genomics, Inc. with a value of $14.8M, Argenx Se with a value of $13.5M, and Pacific Biosciences Of California, Inc. with a value of $12.2M.

Examining the 13F form we can see an decrease of $7.97M in the current position value, from $189M to 181M.

Below you can find more details about Decheng Capital Management Iii (Cayman), LLC portfolio as well as his latest detailed transactions.

Portfolio value $181 Million
Healthcare: $181 Million

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $181 Million
  • Prior Value $189 Million
  • Filing
  • Period Q3 2023
  • Filing Date November 13, 2023
  • Form Type 13F-HR
  • Activity in Q3 2023
  • New Purchases 5 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Decheng Capital Management Iii (Cayman), LLC Portfolio

Follow Decheng Capital Management Iii (Cayman), LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital Management Iii (Cayman), LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital Management Iii (Cayman), LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email